MEOX2 and central nervous system cancer: In conclusion, in the present study, we demonstrated that transcription factor MEOX2 could serve as a poor prognostic indicator in glioma, and MEOX2-CTSS axis contributes to the malignant progression of glioma by regulation of EMT and focal adhesion.